|
|||||||||||||||
|
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016 Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI) |
||||||||||||||
Issue: April 2024
Volume 9 | Issue 4
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.76
Issue per Year : 12
Volume Published : 9
Issue Published : 95
Article Submitted :
Article Published :
Total Authors :
Total Reviewer :
Total Countries :
Indexing Partner
Join RMS/Earn 300
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | Formulation and evaluation of Bromhexine HCl sugar free syrup |
| Authors Name: | Ayesha mohamed shareef shaikh , Dr. Mohammad Wais |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJNRD_203988
|
| Published Paper Id: | IJNRDTH00076 |
| Published In: | Volume 8 Issue 8, August-2023 |
| DOI: | |
| Abstract: | Sugar-free Bromhexine hydrochloride (HCl) syrup represents an innovative formulation designed to provide the benefits of mucolytic and expectorant therapy while catering to individuals with dietary restrictions or preferences. This abstract offers a comprehensive overview of sugar-free Bromhexine HCl syrup, including its composition, mechanism of action, therapeutic applications, potential advantages, and considerations. Sugar-free Bromhexine HCl syrup is formulated to address respiratory conditions characterized by excessive mucus production and impaired clearance, while simultaneously addressing concerns related to sugar intake. Bromhexine HCl, the active ingredient, acts on the respiratory tract by modifying mucus viscosity and enhancing its clearance. This mechanism supports improved airway hygiene, reduced cough severity, and enhanced expectoration. Clinical studies have highlighted the efficacy of sugar-free Bromhexine HCl syrup in managing various respiratory disorders, including acute and chronic bronchitis, chronic obstructive pulmonary disease (COPD), and conditions featuring thickened mucus. By offering a sugar-free alternative, this formulation is particularly suitable for individuals with diabetes, dietary restrictions, or those who prefer to minimize sugar consumption. The key considerations associated with sugar-free Bromhexine HCl syrup use, such as appropriate dosing guidelines, potential side effects, and contraindications. It emphasizes the importance of healthcare professional guidance to ensure safe and effective administration, especially for patients with underlying medical conditions or those taking other medications. In conclusion, sugar-free Bromhexine HCl syrup presents a promising solution for managing respiratory conditions while addressing dietary concerns. Its mucolytic and expectorant properties contribute to improved mucus clearance and cough relief, making it a valuable option for a diverse range of patients. However, individual patient factors and medical history should be carefully evaluated by healthcare providers before prescribing sugar-free Bromhexine HCl syrup. |
| Keywords: | Sugar-free, Bromhexine hydrochloride, mucolytic, expectorant, mucus clearance, respiratory disorders, bronchitis, chronic obstructive pulmonary disease (COPD), dietary restrictions, cough relief. |
| Cite Article: | "Formulation and evaluation of Bromhexine HCl sugar free syrup", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.8, Issue 8, page no.942-965, August-2023, Available :http://www.ijnrd.org/papers/IJNRDTH00076.pdf |
| Downloads: | 000118774 |
| ISSN: |
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID:IJNRDTH00076 Registration ID: 203988 Published In: Volume 8 Issue 8, August-2023 DOI (Digital Object Identifier): Page No: 942-965 Country: mumbai, Maharashtra, India Research Area: Pharmacy Publisher : IJ Publication Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRDTH00076 Published Paper PDF: https://www.ijnrd.org/papers/IJNRDTH00076 |
| Share Article: |
|
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijnrd.org
| Semantic Scholar | Microsaoft Academic | ORCID | Zenodo |
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | PUBLON |
| DRJI | SSRN | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Social Media
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Join RMS/Earn 300
| Copyright © 2024 - All Rights Reserved - IJNRD |
Facebook Twitter Instagram LinkedIn